This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Drug Conjugates
August 16-17, 2023
Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST
Menu

Benjamin Oshrine
Medical Director at Immunogen, USA
Speaker

Agenda Sessions

  • Pivekimab Sunirine (IMGN632): A Next-Generation ADC for CD123+ Hematologic Malignancies

    , 10:35
    View Session

At this event

Prev
Next
Sujiet Puthenveetil
Director
AstraZeneca, USA

See Benjamin at Antibody Drug Conjugates